CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 98 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01 CA238039
NIH
Grant: R01 CA251599
NIH
Grant: P01 CA163222
NIH
Grant: R01 CA234018
Department of Defense Distinguished Investigator Award
Grant: W81XWH-18-1-0469
2018 AACR-AstraZeneca Lung Cancer Research Fellowship
Grant: 18-40-12-KUMA
NIH
Grant: R01 GM120607
T32 training grant
Grant: T32 CA207021
National Institutes of Health
Grant: 5R01GM120607-04
Genomic profiling of pathological R-loop formation in human diseases.
National Institutes of Health
Grant: 5T32CA207021-04
Cancer Immunology Training Grant
National Institutes of Health
Grant: 5R01CA251599-02
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
National Institutes of Health
Grant: 5R01CA234018-02
Regulators of Cancer Immunotherapy Response
National Institutes of Health
Grant: 5P01CA163222-08
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
FWCI
5.06
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals